Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 14 entries
Sorted by: Best Match Show Resources per page
The natural history of napkin-ring sign by coronary computed tomography angiography.

Postepy w kardiologii interwencyjnej = Advances in interventional cardiology

Brutkiewicz A, Kruk M, Demkow M, Maurovich-Horvat P, Pleban W, Witowicz A, Pręgowski J, Dzielinska Z, Ruzyllo W, Kępka C.
PMID: 31592255
Postepy Kardiol Interwencyjnej. 2019;15(3):314-320. doi: 10.5114/aic.2019.87886. Epub 2019 Sep 18.

INTRODUCTION: Despite their significance, the prevalence and the incidence of vulnerable plaques in coronary arteries, as well as their natural history, remain poorly known.AIM: To evaluate the prevalence, incidence and evolution of napkin-ring sign (NRS), and to establish factors...

Cite
Brutkiewicz A, Kruk M, Demkow M, et al. The natural history of napkin-ring sign by coronary computed tomography angiography. Postepy Kardiol Interwencyjnej. 2019;15(3):314-320doi: 10.5114/aic.2019.87886.
Brutkiewicz, A., Kruk, M., Demkow, M., Maurovich-Horvat, P., Pleban, W., Witowicz, A., Pręgowski, J., Dzielinska, Z., Ruzyllo, W., & Kępka, C. (2019). The natural history of napkin-ring sign by coronary computed tomography angiography. Postepy w kardiologii interwencyjnej = Advances in interventional cardiology, 15(3), 314-320. https://doi.org/10.5114/aic.2019.87886
Brutkiewicz, Aleksandra, et al. "The natural history of napkin-ring sign by coronary computed tomography angiography." Postepy w kardiologii interwencyjnej = Advances in interventional cardiology vol. 15,3 (2019): 314-320. doi: https://doi.org/10.5114/aic.2019.87886
Brutkiewicz A, Kruk M, Demkow M, Maurovich-Horvat P, Pleban W, Witowicz A, Pręgowski J, Dzielinska Z, Ruzyllo W, Kępka C. The natural history of napkin-ring sign by coronary computed tomography angiography. Postepy Kardiol Interwencyjnej. 2019;15(3):314-320. doi: 10.5114/aic.2019.87886. Epub 2019 Sep 18. PMID: 31592255; PMCID: PMC6777192.
Copy Download .nbib Format: NLM
Black and Pink: Single Lesion or Double Diagnosis?.

Dermatology practical & conceptual

Proietti I, Di Fraia M, Michelini S, Colapietra D, Rullo E, Porta N, Petrozza V, Skroza N, Potenza C.
PMID: 31921512
Dermatol Pract Concept. 2019 Dec 31;10(1):e2020025. doi: 10.5826/dpc.1001a25. eCollection 2020.

No abstract available.

Cite
Proietti I, Di Fraia M, Michelini S, et al. Black and Pink: Single Lesion or Double Diagnosis?. Dermatol Pract Concept. 2019;10(1):e2020025doi: 10.5826/dpc.1001a25.
Proietti, I., Di Fraia, M., Michelini, S., Colapietra, D., Rullo, E., Porta, N., Petrozza, V., Skroza, N., & Potenza, C. (2020). Black and Pink: Single Lesion or Double Diagnosis?. Dermatology practical & conceptual, 10(1), e2020025. https://doi.org/10.5826/dpc.1001a25
Proietti, Ilaria, et al. "Black and Pink: Single Lesion or Double Diagnosis?." Dermatology practical & conceptual vol. 10,1 (2020): e2020025. doi: https://doi.org/10.5826/dpc.1001a25
Proietti I, Di Fraia M, Michelini S, Colapietra D, Rullo E, Porta N, Petrozza V, Skroza N, Potenza C. Black and Pink: Single Lesion or Double Diagnosis?. Dermatol Pract Concept. 2019 Dec 31;10(1):e2020025. doi: 10.5826/dpc.1001a25. eCollection 2020. PMID: 31921512; PMCID: PMC6936632.
Copy Download .nbib Format: NLM
Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial.

European heart journal. Cardiovascular pharmacotherapy

De Caterina R, Patti G, Westerbergh J, Horowitz J, Ezekowitz JA, Lewis BS, Lopes RD, McMurray JJV, Atar D, Bahit MC, Keltai M, López-Sendón JL, Ruzyllo W, Granger CB, Alexander JH, Wallentin L.
PMID: 33367487
Eur Heart J Cardiovasc Pharmacother. 2020 Dec 28; doi: 10.1093/ehjcvp/pvaa140. Epub 2020 Dec 28.

AIMS: Whether diabetes without insulin therapy is an independent cardiovascular (CV) risk factor in atrial fibrillation (AF) has recently been questioned. We investigated the prognostic relevance of diabetes with or without insulin treatment in patients in the ARISTOTLE trial.METHODS...

Cite
De Caterina R, Patti G, Westerbergh J, et al. Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial. Eur Heart J Cardiovasc Pharmacother. 2020;doi: 10.1093/ehjcvp/pvaa140.
De Caterina, R., Patti, G., Westerbergh, J., Horowitz, J., Ezekowitz, J. A., Lewis, B. S., Lopes, R. D., McMurray, J. J. V., Atar, D., Bahit, M. C., Keltai, M., López-Sendón, J. L., Ruzyllo, W., Granger, C. B., Alexander, J. H., & Wallentin, L. (2020). Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial. European heart journal. Cardiovascular pharmacotherapy, . https://doi.org/10.1093/ehjcvp/pvaa140
De Caterina, Raffaele, et al. "Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial." European heart journal. Cardiovascular pharmacotherapy vol. (2020). doi: https://doi.org/10.1093/ehjcvp/pvaa140
De Caterina R, Patti G, Westerbergh J, Horowitz J, Ezekowitz JA, Lewis BS, Lopes RD, McMurray JJV, Atar D, Bahit MC, Keltai M, López-Sendón JL, Ruzyllo W, Granger CB, Alexander JH, Wallentin L. Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial. Eur Heart J Cardiovasc Pharmacother. 2020 Dec 28; doi: 10.1093/ehjcvp/pvaa140. Epub 2020 Dec 28. PMID: 33367487.
Copy Download .nbib Format: NLM
High-Pressure Bail-out Coronary Stenting Without Anticoagulation: Early Outcome and Follow-up Results.

The Journal of invasive cardiology

Witkowski A, Chmielak Z, Dabrowski M, Jodkowski J, Demkow M, Debski A, Gorecka B, Ruzyllo W.
PMID: 10762771
J Invasive Cardiol. 1998 Mar;10(2):83-88.

PURPOSE:The purpose of this study is to assess the immediate outcome and long-term results of high pressure bail-out coronary stenting without subsequent anticoagulation. PATIENTS AND METHODS: Between June 1994 and September 1996, 32 consecutive patients (males 24, mean age...

Cite
Witkowski A, Chmielak Z, Dabrowski M, et al. High-Pressure Bail-out Coronary Stenting Without Anticoagulation: Early Outcome and Follow-up Results. J Invasive Cardiol. 1998;10(2):83-88
Witkowski, A., Chmielak, Z., Dabrowski, M., Jodkowski, J., Demkow, M., Debski, A., Gorecka, B., & Ruzyllo, W. (1998). High-Pressure Bail-out Coronary Stenting Without Anticoagulation: Early Outcome and Follow-up Results. The Journal of invasive cardiology, 10(2), 83-88.
Witkowski, et al. "High-Pressure Bail-out Coronary Stenting Without Anticoagulation: Early Outcome and Follow-up Results." The Journal of invasive cardiology vol. 10,2 (1998): 83-88.
Witkowski A, Chmielak Z, Dabrowski M, Jodkowski J, Demkow M, Debski A, Gorecka B, Ruzyllo W. High-Pressure Bail-out Coronary Stenting Without Anticoagulation: Early Outcome and Follow-up Results. J Invasive Cardiol. 1998 Mar;10(2):83-88. PMID: 10762771.
Copy Download .nbib Format: NLM
[Examination as an adequate criterion of evaluation of specialist training].

Polski tygodnik lekarski (Warsaw, Poland : 1960)

Ruzyllo E.
PMID: 5703508
Pol Tyg Lek. 1968 Oct 21;23(43):1660-2.

No abstract available.

Cite
Ruzyllo E. Egzamin, jako miarodajne kryterium oceny przygotowania specjalistycznego. [Examination as an adequate criterion of evaluation of specialist training]. Pol Tyg Lek. 1968;23(43):1660-2
Ruzyllo, E. (1968). Egzamin, jako miarodajne kryterium oceny przygotowania specjalistycznego. [Examination as an adequate criterion of evaluation of specialist training]. Polski tygodnik lekarski (Warsaw, Poland : 1960), 23(43), 1660-2.
Ruzyllo, E. "Egzamin, jako miarodajne kryterium oceny przygotowania specjalistycznego." [Examination as an adequate criterion of evaluation of specialist training]. Polski tygodnik lekarski (Warsaw, Poland : 1960) vol. 23,43 (1968): 1660-2.
Ruzyllo E. Egzamin, jako miarodajne kryterium oceny przygotowania specjalistycznego. [Examination as an adequate criterion of evaluation of specialist training]. Pol Tyg Lek. 1968 Oct 21;23(43):1660-2. Polish. PMID: 5703508.
Copy Download .nbib Format: NLM
Symposium on obesity.

Polskie Archiwum Medycyny Wewnetrznej

Ruzyllo E.
PMID: 5790045
Pol Arch Med Wewn. 1969;42(3):289-90.

No abstract available.

Cite
Ruzyllo E. Symposium on obesity. Pol Arch Med Wewn. 1969;42(3):289-90
Ruzyllo, E. (1969). Symposium on obesity. Polskie Archiwum Medycyny Wewnetrznej, 42(3), 289-90.
Ruzyllo, E. "Symposium on obesity." Polskie Archiwum Medycyny Wewnetrznej vol. 42,3 (1969): 289-90.
Ruzyllo E. Symposium on obesity. Pol Arch Med Wewn. 1969;42(3):289-90. PMID: 5790045.
Copy Download .nbib Format: NLM
Staged transcatheter closure of chronic postinfarction ventricular septal defects with the Amplatzer septal occluder.

International journal of cardiovascular interventions

Demkow M, Ruzyllo W, Konka M, Wilczynski J, Dzielinska Z, Kochman J.
PMID: 12431340
Int J Cardiovasc Intervent. 2001 Mar;4(1):43-48. doi: 10.1080/146288401316922698.

Ventricular septal rupture is a serious complication of myocardial infarction with an extremely poor outcome. There are single reports of transcatheter closure of postmyocardial septal defects and clinical experience is limited. This paper reports on a successful staged transcatheter...

Cite
Demkow M, Ruzyllo W, Konka M, et al. Staged transcatheter closure of chronic postinfarction ventricular septal defects with the Amplatzer septal occluder. Int J Cardiovasc Intervent. 2001;4(1):43-48doi: 10.1080/146288401316922698.
Demkow, M., Ruzyllo, W., Konka, M., Wilczynski, J., Dzielinska, Z., & Kochman, J. (2001). Staged transcatheter closure of chronic postinfarction ventricular septal defects with the Amplatzer septal occluder. International journal of cardiovascular interventions, 4(1), 43-48. https://doi.org/10.1080/146288401316922698
Demkow, Marcin, et al. "Staged transcatheter closure of chronic postinfarction ventricular septal defects with the Amplatzer septal occluder." International journal of cardiovascular interventions vol. 4,1 (2001): 43-48. doi: https://doi.org/10.1080/146288401316922698
Demkow M, Ruzyllo W, Konka M, Wilczynski J, Dzielinska Z, Kochman J. Staged transcatheter closure of chronic postinfarction ventricular septal defects with the Amplatzer septal occluder. Int J Cardiovasc Intervent. 2001 Mar;4(1):43-48. doi: 10.1080/146288401316922698. PMID: 12431340.
Copy Download .nbib Format: NLM
Postgraduate medical studies in Poland.

British journal of medical education

Ruzyllo E.
PMID: 5498810
Br J Med Educ. 1970 Dec;4(4):262-7.

No abstract available.

Cite
Ruzyllo E. Postgraduate medical studies in Poland. Br J Med Educ. 1970;4(4):262-7
Ruzyllo, E. (1970). Postgraduate medical studies in Poland. British journal of medical education, 4(4), 262-7.
Ruzyllo, E. "Postgraduate medical studies in Poland." British journal of medical education vol. 4,4 (1970): 262-7.
Ruzyllo E. Postgraduate medical studies in Poland. Br J Med Educ. 1970 Dec;4(4):262-7. PMID: 5498810.
Copy Download .nbib Format: NLM
Primary transcatheter closure of postinfarction ventricular septal defects with the Amplatzer septal occluder- immediate results and up-to 5 years follow-up.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Demkow M, Ruzyllo W, Kepka C, Chmielak Z, Konka M, Dzielinska Z, Wilczynski J, Juraszynski Z.
PMID: 19758875
EuroIntervention. 2005 May;1(1):43-7.

AIM: To report the periprocedural and long-term results of using the Amplatzer septal occluder for primary closure of post myocardial infarction ventricular septal defects.METHODS AND RESULTS: Transcatheter closure was considered in patients with significant left-to-right shunting and defect anatomy...

Cite
Demkow M, Ruzyllo W, Kepka C, et al. Primary transcatheter closure of postinfarction ventricular septal defects with the Amplatzer septal occluder- immediate results and up-to 5 years follow-up. EuroIntervention. 2005;1(1):43-7
Demkow, M., Ruzyllo, W., Kepka, C., Chmielak, Z., Konka, M., Dzielinska, Z., Wilczynski, J., & Juraszynski, Z. (2005). Primary transcatheter closure of postinfarction ventricular septal defects with the Amplatzer septal occluder- immediate results and up-to 5 years follow-up. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 1(1), 43-7.
Demkow, M, et al. "Primary transcatheter closure of postinfarction ventricular septal defects with the Amplatzer septal occluder- immediate results and up-to 5 years follow-up." EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology vol. 1,1 (2005): 43-7.
Demkow M, Ruzyllo W, Kepka C, Chmielak Z, Konka M, Dzielinska Z, Wilczynski J, Juraszynski Z. Primary transcatheter closure of postinfarction ventricular septal defects with the Amplatzer septal occluder- immediate results and up-to 5 years follow-up. EuroIntervention. 2005 May;1(1):43-7. PMID: 19758875.
Copy Download .nbib Format: NLM
Outcomes in non-ST-segment elevation myocardial infarction patients according to heart failure at admission: Insights from a large trial with systematic early invasive strategy.

European heart journal. Acute cardiovascular care

Popovic B, Sorbets E, Abtan J, Cohen M, Pollack CV, Bode C, Wiviott SD, Sabatine MS, Mehta SR, Ruzyllo W, Rao SV, French WJ, Kerkar P, Kiss RG, Estrada JLN, Elbez Y, Ducrocq G, Steg PG.
PMID: 33081496
Eur Heart J Acute Cardiovasc Care. 2020 Oct 20;2048872619896205. doi: 10.1177/2048872619896205. Epub 2020 Oct 20.

BACKGROUND: Previous studies published before the era of systematic early invasive strategy have reported a higher mortality in non-ST-segment elevation myocardial infarction patients with heart failure. The aim of our study was to compare the clinical characteristics, outcomes and...

Cite
Popovic B, Sorbets E, Abtan J, et al. Outcomes in non-ST-segment elevation myocardial infarction patients according to heart failure at admission: Insights from a large trial with systematic early invasive strategy. Eur Heart J Acute Cardiovasc Care. 2020;2048872619896205doi: 10.1177/2048872619896205.
Popovic, B., Sorbets, E., Abtan, J., Cohen, M., Pollack, C. V., Bode, C., Wiviott, S. D., Sabatine, M. S., Mehta, S. R., Ruzyllo, W., Rao, S. V., French, W. J., Kerkar, P., Kiss, R. G., Estrada, J. L. N., Elbez, Y., Ducrocq, G., Steg, P. G. (2020). Outcomes in non-ST-segment elevation myocardial infarction patients according to heart failure at admission: Insights from a large trial with systematic early invasive strategy. European heart journal. Acute cardiovascular care, 2048872619896205. https://doi.org/10.1177/2048872619896205
Popovic, Batric, et al. "Outcomes in non-ST-segment elevation myocardial infarction patients according to heart failure at admission: Insights from a large trial with systematic early invasive strategy." European heart journal. Acute cardiovascular care vol. (2020): 2048872619896205. doi: https://doi.org/10.1177/2048872619896205
Popovic B, Sorbets E, Abtan J, Cohen M, Pollack CV, Bode C, Wiviott SD, Sabatine MS, Mehta SR, Ruzyllo W, Rao SV, French WJ, Kerkar P, Kiss RG, Estrada JLN, Elbez Y, Ducrocq G, Steg PG. Outcomes in non-ST-segment elevation myocardial infarction patients according to heart failure at admission: Insights from a large trial with systematic early invasive strategy. Eur Heart J Acute Cardiovasc Care. 2020 Oct 20;2048872619896205. doi: 10.1177/2048872619896205. Epub 2020 Oct 20. PMID: 33081496.
Copy Download .nbib Format: NLM
Outcomes in non-ST-segment elevation myocardial infarction patients according to heart failure at admission: Insights from a large trial with systematic early invasive strategy.

European heart journal. Acute cardiovascular care

Popovic B, Sorbets E, Abtan J, Cohen M, Pollack CV, Bode C, Wiviott SD, Sabatine MS, Mehta SR, Ruzyllo W, Rao SV, French WJ, Kerkar P, Kiss RG, Estrada JLN, Elbez Y, Ducrocq G, Steg PG.
PMID: 33609103
Eur Heart J Acute Cardiovasc Care. 2020 Oct 20; doi: 10.1177/2048872619896205. Epub 2020 Oct 20.

BACKGROUND: Previous studies published before the era of systematic early invasive strategy have reported a higher mortality in non-ST-segment elevation myocardial infarction patients with heart failure. The aim of our study was to compare the clinical characteristics, outcomes and...

Cite
Popovic B, Sorbets E, Abtan J, et al. Outcomes in non-ST-segment elevation myocardial infarction patients according to heart failure at admission: Insights from a large trial with systematic early invasive strategy. Eur Heart J Acute Cardiovasc Care. 2020;doi: 10.1177/2048872619896205.
Popovic, B., Sorbets, E., Abtan, J., Cohen, M., Pollack, C. V., Bode, C., Wiviott, S. D., Sabatine, M. S., Mehta, S. R., Ruzyllo, W., Rao, S. V., French, W. J., Kerkar, P., Kiss, R. G., Estrada, J. L. N., Elbez, Y., Ducrocq, G., & Steg, P. G. (2020). Outcomes in non-ST-segment elevation myocardial infarction patients according to heart failure at admission: Insights from a large trial with systematic early invasive strategy. European heart journal. Acute cardiovascular care, . https://doi.org/10.1177/2048872619896205
Popovic, Batric, et al. "Outcomes in non-ST-segment elevation myocardial infarction patients according to heart failure at admission: Insights from a large trial with systematic early invasive strategy." European heart journal. Acute cardiovascular care vol. (2020). doi: https://doi.org/10.1177/2048872619896205
Popovic B, Sorbets E, Abtan J, Cohen M, Pollack CV, Bode C, Wiviott SD, Sabatine MS, Mehta SR, Ruzyllo W, Rao SV, French WJ, Kerkar P, Kiss RG, Estrada JLN, Elbez Y, Ducrocq G, Steg PG. Outcomes in non-ST-segment elevation myocardial infarction patients according to heart failure at admission: Insights from a large trial with systematic early invasive strategy. Eur Heart J Acute Cardiovasc Care. 2020 Oct 20; doi: 10.1177/2048872619896205. Epub 2020 Oct 20. PMID: 33609103.
Copy Download .nbib Format: NLM
Circulating CD137.

Clinical cancer research : an official journal of the American Association for Cancer Research

Zizzari IG, Di Filippo A, Botticelli A, Strigari L, Pernazza A, Rullo E, Pignataro MG, Ugolini A, Scirocchi F, Di Pietro FR, Rossi E, Gelibter A, Schinzari G, d'Amati G, Rughetti A, Marchetti P, Nuti M, Napoletano C.
PMID: 34980602
Clin Cancer Res. 2022 Jan 03; doi: 10.1158/1078-0432.CCR-21-2918. Epub 2022 Jan 03.

PURPOSE: CD137 molecule is expressed by activated lymphocytes, and in cancer patients identifies the tumor-reactive Tcells. In solid tumors, high levels of circulating CD137EXPERIMENTAL DESIGN: PBMC derived from 109 metastatic cancer patients (66 patients for the identification cohort and...

Cite
Zizzari IG, Di Filippo A, Botticelli A, et al. Circulating CD137. Clin Cancer Res. 2022;doi: 10.1158/1078-0432.CCR-21-2918.
Zizzari, I. G., Di Filippo, A., Botticelli, A., Strigari, L., Pernazza, A., Rullo, E., Pignataro, M. G., Ugolini, A., Scirocchi, F., Di Pietro, F. R., Rossi, E., Gelibter, A., Schinzari, G., d'Amati, G., Rughetti, A., Marchetti, P., Nuti, M., & Napoletano, C. (2022). Circulating CD137. Clinical cancer research : an official journal of the American Association for Cancer Research, . https://doi.org/10.1158/1078-0432.CCR-21-2918
Zizzari, Ilaria Grazia, et al. "Circulating CD137." Clinical cancer research : an official journal of the American Association for Cancer Research vol. (2022). doi: https://doi.org/10.1158/1078-0432.CCR-21-2918
Zizzari IG, Di Filippo A, Botticelli A, Strigari L, Pernazza A, Rullo E, Pignataro MG, Ugolini A, Scirocchi F, Di Pietro FR, Rossi E, Gelibter A, Schinzari G, d'Amati G, Rughetti A, Marchetti P, Nuti M, Napoletano C. Circulating CD137. Clin Cancer Res. 2022 Jan 03; doi: 10.1158/1078-0432.CCR-21-2918. Epub 2022 Jan 03. PMID: 34980602.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 14 entries